Gedeon Richter — Case study | Clarivate Regulatory Intelligence Tracking Application
Gedeon Richter Plc., a major Hungarian pharmaceutical company, needed to streamline business-specific regulatory monitoring and impact assessments; staff previously traveled to EMA/FDA sites and manually emailed downloaded documents to subject matter experts, an inefficient and error-prone process. Gedeon Richter became one of the earliest subscribers to Clarivate's Regulatory Intelligence Tracking Application, an AI-powered, end-to-end solution offering a customizable dashboard, automated daily processing of new regulations, a searchable global storage solution, and automated alerts/newsletters. Recent enhancements include self-service notification subscriptions and auto-status mapping rules that save "more than four clicks per document," multiplied across hundreds of daily documents. The company now has more visibility into regulatory changes and reinvests time previously spent on manual triage into higher-value impact assessments. Kinga Pallay, Regulatory Intelligence Expert at Gedeon Richter, stated: "Clarivate has been very approachable and responsive to taking our business needs into consideration... We are now able to efficiently triage and manage our regulatory alerts, send out newsletters with ease and so much more!"
Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Clarivate on its own site — read the original case study on clarivate.com ↗
Related use cases
- 01How Bioventus evolved their commercial strategy with real world data and intelligence
- 02Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 03Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study
- 04Integrating patient centricity into the Menarini mature brand strategy for commercial excellence
- 05Artificial Intelligence in Pharmacovigilance: Using AI to help GSK detect ICSRs in scientific literature
- 06Monitoring the rare diseases landscape